MONOGRAPH LIBRARY
Topicals, injectables, procedures, hair loss treatments.
A powerful carotenoid antioxidant supporting eye health, athletic recovery, and cardiovascular function
Hydrolyzed peptides supporting skin, joint, and connective tissue health through targeted amino acid delivery
5-alpha reductase inhibitor: approved for BPH, off-label for androgenetic alopecia
5-Alpha Reductase Inhibition for Prostate Health and Hair Preservation
Cosmetic Peptide With Topical Benefits and Injectable Research Status
An essential amino acid supporting collagen synthesis, immune function, and herpes simplex virus management
FDA-approved OTC topical for hair loss; oral off-label but increasingly prescribed
Minoxidil is a potassium channel opener originally developed as an antihypertensive in the 1970s. The hair-growth side effect was noticed quickly; topical minoxidil was approved for androgenetic alopecia in 1988 and became the dominant…
Traditional herbal extract with EMA monograph for prostate and urinary health
Setipiprant is a small-molecule antagonist of the prostaglandin D2 receptor 2 (DP2, also called CRTH2). It was originally developed as a potential treatment for asthma and allergic disorders due to PGD2's role in inflammatory responses. In 2012, a…
Oral finasteride (1 mg/day) and oral dutasteride (0.5 mg/day) are the most-evidenced medical therapies for male androgenetic alopecia. Both work by inhibiting 5-alpha reductase, the enzyme that converts testosterone to the more potent…
Antioxidant and collagen synthesis cofactor for immunity and connective tissue health
Azelaic acid is available in FDA-approved prescription formulations: Finacea 15% (for mild to moderate rosacea) and Azelex 20% (for mild to moderate acne vulgaris).
Plant-derived cosmetic; not drug-regulated; retinol alternative marketed globally
OTC superficial peels are cosmetics; professional/medical peels are regulated procedures
Exosomes are nanoscale (30-150 nm) extracellular vesicles released by virtually all cell types as a normal mechanism of intercellular signaling. They carry a defined cargo of proteins, lipids, mRNA, and microRNAs that reflects the parent cell's…
Topical cosmetic (unregulated); injectable fillers FDA-cleared as medical devices (not drug-approved)
Hypochlorous acid (HOCl) is an endogenous molecule produced by neutrophils as part of the innate immune system's pathogen defense. It is a potent oxidizing agent that kills bacteria, fungi, and viruses through oxidation of microbial proteins, while…
Mandelic acid is an alpha-hydroxy acid (AHA) derived from bitter almonds. It is structurally similar to glycolic acid and lactic acid but with a substantially larger molecular structure (152.15 g/mol vs glycolic at 76 g/mol). The larger molecule…
Methylene blue (methylthioninium chloride) is a phenothiazine dye first synthesized in 1876 and used clinically for over a century — as a treatment for methemoglobinemia (FDA-approved indication), as a urinary tract analgesic, and as a surgical dye…
Device-regulated procedure; professional devices cleared; home devices <0.5mm less regulated
Well-tolerated cosmetic ingredient; anti-inflammatory and barrier support
Sculptra (poly-L-lactic acid, PLLA) is an injectable biostimulator developed by Sanofi-Aventis (now Galderma). Unlike hyaluronic acid (HA) fillers, which physically occupy volume at injection sites, Sculptra works by triggering a controlled…
Polynucleotides (PN) are short fragments of DNA, typically extracted from the gonadal tissue of Pacific salmon, processed to produce a defined molecular-weight range of nucleotide chains. The most-recognized branded product is Rejuran…
Device-regulated autologous procedure; PRP device FDA-cleared but aesthetic applications investigational
Device-regulated centrifuge; procedure unregulated; emerging evidence for joint pain and tendinopathy
Device-regulated; FDA-cleared for pain and wound healing; off-label anti-aging and cognitive use emerging
FDA OTC drug monograph; EU offers wider filter options; US lags in approved filters
Antioxidant cosmetic ingredient; not drug-regulated globally, quality varies enormously
Gold standard retinoid for photoaging and acne; prescription-only globally
Evidence-based multi-compound protocol for androgenetic alopecia addressing DHT, micro-inflammation, and hair growth signaling
Protocol Guide Series / April 2026 / FOR VANGUARD MEMBERS ONLY — Protocol Skinhairoptimization
Hair transplantation moves hair from a donor area at the back and sides of the scalp (which is genetically resistant to DHT-mediated miniaturization) to a recipient area at the front and crown (which is not). The transplanted hairs retain their…
Ketoconazole is an imidazole antifungal medication. As a topical shampoo (typically 2% ketoconazole in the United States as Nizoral, 1% as Nizoral A-D OTC, with various international generics), it is FDA-approved for treatment of seborrheic…
As of mid-2026, Kintor reports that the pivotal Phase III stage in China met its primary endpoint with statistically significant and clinically meaningful efficacy in male AGA; a 52-week long-term safety Phase III also met endpoint. US Phase II positive. NDA planned in China.
RU58841 (also called PSK-3841) is a non-steroidal topical antiandrogen developed by Roussel Uclaf (later Sanofi) in the late 1980s and 1990s as a topical treatment for androgenetic alopecia (AGA, male and female pattern hair loss). It is a pure…
Bug report, content request, or general comment — we read everything.